2025-09-11 - Analysis Report
Okay, here's an analysis of Intuitive Surgical Inc. (ISRG), incorporating all the provided information:

## ISRG Analysis: Intuitive Surgical Inc.

**Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return ISRG:** 100.48%
*   **Cumulative Return VOO:** 39.61%
*   **Outperformance:** ISRG has significantly outperformed the S&P 500 over the analyzed period.
*   **Absolute Deviation:** 60.87% (ISRG - VOO)
*   **Deviation Range:** (Max: 127.7, Min: -6.8)
*   **Current Deviation Relative Position:** 5.4 (Relatively low deviation, positioned towards the lower end of its historical outperformance range.)
*   **Analysis:** While ISRG has historically shown strong outperformance, the current relative deviation suggests this outperformance is less pronounced compared to its historical peaks.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
| ---------- | ------ | ------ | ------ | ------ | ------ |
| 2015-2017  | 68.0%  | 56.5%  | 68.0   | 1.0    | 42.0   |
| 2016-2018  | 77.0%  | 63.4%  | 77.0   | 1.0    | 55.1   |
| 2017-2019  | 81.0%  | 63.4%  | 81.0   | 1.0    | 68.0   |
| 2018-2020  | 47.0%  | 63.4%  | 47.0   | 1.0    | 94.1   |
| 2019-2021  | 91.0%  | 63.0%  | 90.0   | -0.0   | 124.0  |
| 2020-2022  | -3.0%  | 69.9%  | 7.0    | -0.1   | 91.5   |
| 2021-2023  | -5.0%  | 72.9%  | -15.0  | -0.0   | 116.4  |
| 2022-2024  | 26.0%  | 72.9%  | -4.0   | -0.0   | 180.1  |
| 2023-2025  | 21.0%  | 72.9%  | -25.0  | 0.0    | 161.3  |

*   **CAGR:** Historically high, but recent years show a decline.
*   **MDD:**  High Maximum Drawdown values indicate significant price volatility.
*   **Alpha:** Recent Alpha values are negative, suggesting underperformance relative to the market on a risk-adjusted basis in the most recent periods.
*   **Beta:** The Beta values indicate that ISRG's price has been relatively independent of overall market movements during the period from 2019-2025.
*   **Cap:**  Market capitalization has generally increased over time, reflecting growth.

### 2. Recent Price Action

*   **Current Price:** 467.54
*   **Last Market Data:**
    *   Price: 449.98
    *   Previous Close: 467.54
    *   Change: -3.76
*   **Moving Averages:**
    *   5-day MA: 460.02
    *   20-day MA: 470.75
    *   60-day MA: 496.52

*   **Analysis:** The stock price is below both its 20-day and 60-day moving averages, suggesting a short-term downtrend. The negative change in the last market price (-3.76) reflects recent selling pressure.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3261 (Low Risk)
*   **RSI:** 44.25 (Neutral - Neither overbought nor oversold)
*   **PPO:** 0.215 (Neutral - indicates where the EMA is in relation to the SMA.)
*   **Hybrid Signal:** cash_1%_Buy 90% of cash (35 shares - Safe - MRI:0.33) (Cash Ratio: 1% on 2025-09-09)
*   **20-day Relative Deviation Change:** -5.2 (Negative, indicating short-term decline relative to VOO)
*   **Expected Return:** 779.3% (Significant long-term outperformance potential vs. S&P 500 if investing from the present moment).

*   **Analysis:**  The MRI suggests a low-risk environment. The negative change in relative deviation and recent price drop are causes for concern. The high Expected Return suggests the stock may be undervalued, but this needs to be balanced against recent negative trends. The Hybrid Signal indicates a conservative approach, suggesting buying a portion of the stock with the majority of funds.

### 4. Recent News & Significant Events

*   **Positive Developments:**
    *   "Ion Platform Poised for Cost Optimization":  Potentially improving margins.
    *   "MemorialCare Launches Da Vinci 5": Expanding adoption of ISRG's technology.
    *   "2 Beaten-Down Stocks to Buy on the Dip": ISRG identified as a potential buy.
*   **Negative Developments/Concerns:**
    *   "Insider Moves and Global Headwinds Reveal a Shift in ISRG’s Strategic Outlook?": Potential change in company strategy or challenges ahead.
    *   "Medtronic trial of Hugo robot in hernia repair hits primary endpoints": Increased competition.
    *   "Intuitive Surgical Stock Has Been Plummeting. Is It Time to Buy?": Highlights recent stock price weakness.
*   **Analysis:**  The news is mixed. While there are positive developments around adoption and potential margin improvements, concerns about competition and strategic shifts need to be considered. The recent price decline is also a key factor.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean = 1.94)
*   **Target Price:** $582.10 (Significant upside from current price)
*   **Analysis:**  Analysts generally view the stock favorably, with a Buy consensus and a target price substantially above the current market price. This suggests analysts believe the recent price weakness is a buying opportunity.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
| ---------- | ---- | ----------- |
| 2025-07-23 | 1.84 | 2.44 B$     |
| 2025-04-23 | 1.95 | 2.25 B$     |
| 2024-10-18 | 1.59 | 2.04 B$     |
| 2024-07-19 | 1.48 | 2.01 B$     |
| 2025-07-23 | 1.48 | 2.01 B$     |

*   **Analysis:**  Both EPS and revenue have generally trended upwards, but with some variability. The lastest Revenue figure demonstrates a robust growth.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
| ---------- | ---------- | --------------- |
| 2025-06-30 | $2.44B    | 66.31%          |
| 2025-03-31 | $2.25B    | 64.69%          |
| 2024-12-31 | $2.41B    | 68.04%          |
| 2024-09-30 | $2.04B    | 67.41%          |
| 2024-06-30 | $2.01B    | 68.30%          |

**Capital and Profitability:**

| Quarter    | Equity     | ROE     |
| ---------- | ---------- | ------- |
| 2025-06-30 | $17.85B   | 3.69%   |
| 2025-03-31 | $17.11B   | 4.08%   |
| 2024-12-31 | $16.43B   | 4.17%   |
| 2024-09-30 | $15.58B   | 3.63%   |
| 2024-06-30 | $14.71B   | 3.58%   |

*   **Analysis:** Revenue is generally growing, with strong profit margins. Equity is increasing, but ROE fluctuates and has decreased slightly in the most recent quarter.

### 7. Summary and Overall Assessment

ISRG presents a mixed picture.

*   **Strengths:**
    *   Historically strong outperformance vs. S&P 500.
    *   High Expected Return.
    *   Positive analyst consensus and price target.
    *   Growing revenue and strong profit margins.
    *   Continued adoption of da Vinci systems.
*   **Weaknesses/Risks:**
    *   Recent price weakness and negative short-term trends.
    *   Increasing competition.
    *   Concerns about strategic shifts and global headwinds.
    *   Fluctuating ROE.
    *   Negative Alpha values in recent periods.

**Overall, ISRG appears to be a company with strong fundamentals and growth potential, but facing some short-term headwinds.** The recent price decline might represent a buying opportunity for long-term investors, especially given the analyst consensus and high expected return. However, it's crucial to carefully monitor the competitive landscape and any strategic shifts within the company. A conservative approach, as suggested by the Hybrid Signal, may be warranted.
